Australian Professional Services Stock News

Reece Limited ( ASX:REH ) has announced that it will pay a dividend of A$0.1186 per share on the 22nd of October. The...

The recent movement in Virgin Australia Holdings (ASX:VGN) shares might have caught the attention of investors on the lookout for signals about the company’s direction. While there is no single major headline driving the action, these kinds of shifts often spark fresh questions for anyone deciding whether to buy, hold, or sell. Sometimes, even quieter trading periods can open the door to opportunities hiding in plain sight. Looking back over the month, Virgin Australia Holdings shares have...

Corporate Travel Management (ASX:CTD) Suspended Amid Accounting Concerns If you own or follow Corporate Travel Management (ASX:CTD), the unexpected news of its trading suspension is probably front of mind. The company has revealed irregularities in its accounts, prompting a pause in trading and a scramble from auditors Deloitte and KPMG to examine the details. CTM says this process may take months, which has fueled uncertainty and left investors weighing both the risks and the possible...

Key Insights James Hardie Industries to hold its Annual General Meeting on 29th of September CEO Aaron Erter's total...

Key Insights Institutions' substantial holdings in OFX Group implies that they have significant influence over the...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Regis Resources Limited ( ASX:RRL ) shareholders would be excited to see that the share price has had a great month...

We wouldn't blame IperionX Limited ( ASX:IPX ) shareholders if they were a little worried about the fact that Melissa...

Genesis Minerals Limited ( ASX:GMD ) shares have had a really impressive month, gaining 26% after a shaky period...

Key Insights The considerable ownership by retail investors in Superloop indicates that they collectively have a...

Key Insights Significant control over Energy One by individual investors implies that the general public has more power...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see SRG Global...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

As global markets react to the Federal Reserve's recent interest rate cut, small-cap stocks have demonstrated notable sensitivity and rallied in response, with the Russell 2000 Index seeing a significant gain. In Asia, economic indicators such as China's retail sales and industrial output reveal a broader slowdown, prompting speculation about potential stimulus measures that could impact small-cap companies across the region. In this context, identifying promising small-cap stocks involves...

Some SHAPE Australia Corporation Limited ( ASX:SHA ) shareholders may be a little concerned to see that the CEO, MD...

It is hard to get excited after looking at Technology One's (ASX:TNE) recent performance, when its stock has declined...

The Australian market has shown a steady rise, gaining 7.2% over the past year with earnings projected to grow by 11% annually. In such conditions, identifying stocks with solid financials can be key to finding opportunities for growth and value. While the term "penny stock" may seem outdated, these smaller or newer companies can still offer significant potential when they are financially robust, presenting investors with unique opportunities for discovering quality investments.

When a company asks for its shares to be placed in a trading halt, investors tend to take notice. That is exactly the spot PYC Therapeutics (ASX:PYC) finds itself in after a one-two punch: the abrupt exit of long-serving CEO Dr Rohan Hockings and the naming of Chairman Alan Tribe as interim Managing Director. The official word is that the halt is tied entirely to these board and management changes, with no new capital raise in the mix. In times like these, it is natural for shareholders to...

SKS Technologies Group Limited recently reported significant financial growth for the fiscal year ending June 2025, including a very large 92% increase in revenue and a 111.8% rise in net profit, alongside the declaration of a fully franked dividend of 6.0 cents per share. This marks a substantial increase in shareholder returns compared to the previous year's 1.0 cent dividend and highlights the impact of robust demand in digital infrastructure and smart technology solutions. We'll look at...

Earlier this week, Race Oncology announced a scientific discovery regarding the composition of the chemotherapy drug Bisantrene and has filed three patent applications based on these findings. This move highlights the company’s continued research efforts to strengthen its intellectual property protection in the oncology treatment space. We’ll explore how Race Oncology’s patent applications on new Bisantrene discoveries may influence its investment narrative and future opportunities. Find...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

Insiders who bought AU$7.06m worth of HMC Capital Limited's ( ASX:HMC ) stock at an average buy price of AU$4.55 over...

Many Telix Pharmaceuticals Limited ( ASX:TLX ) insiders ditched their stock over the past year, which may be of...

Radiopharm Theranostics ( ASX:RAD ) Full Year 2025 Results Key Financial Results Net loss: AU$38.3m (loss narrowed by...